TCTR20170827002已完成4 期
The effect of selenium supplementation in moderate-to-severe thyroid eye disease patients : a randomized-placebo controlled trial
The Ratchadapiseksompotch Fund, Faculty of Medicine0 个研究点目标入组 46 人开始时间: 2017年8月27日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 46
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1.The patients who have been categorized into moderate-to-severe thyroid eye disease group according to EUGOGO recommendation.
- •2. Age above 18 years old
- •3. The patients with normal thyroid hormone level (FT4, FT3) for at least 6 months
- •4. The patients who presented with thyroid eye symptoms of less than 18 months.
排除标准
- •1. The patients who have history of allergic reaction to selenium
- •2. The patients who previously took or who are currently taking selenium supplement.
- •3. The patients who are pregnant or breast-feeding.
研究者
相似试验
招募中
3 期
effect of selenium in systemic lupus erythematosusIRCT20210717051914N2Ahvaz University of Medical Sciences56
尚未招募
3 期
The effect of supplementation with organic selenium on sperm parameters, serum levels of androgens, sexual function, and quality of sexual life in infertile meMale infertilityIRCT20131009014957N11Tabriz University of Medical Sciences80
已完成
2 期
The effect of selenium on nephropathy complications of diabetic patientsnon-insulin-dependent diabetes mellitus with renal complicationsE11.2diabetic nephropathy.IRCT2015060622562N1Vice chancellor for research, Kashan University of Medical Sciences60
招募中
2 期
Evaluation of the effect of selenium on patients with thyroid cancer treated with radioactive iodineThyroid cancer.Neoplasm of uncertain behavior of thyroid glandD44.0IRCT20201129049534N6Esfahan University of Medical Sciences60
已完成
2 期
Investigation of the effect of Selenium in beta thalassemia majorthalassemia major.Beta thalassemiaD56.1IRCT20180603039959N3Ahvaz University of Medical Sciences42